Talk:Guduchi: Difference between revisions
No edit summary |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Guduchi (Tinospora cordifolia (WILLD.) HOOK.F. & THOMS.) | Guduchi (Tinospora cordifolia (WILLD.) HOOK.F. & THOMS.) | ||
''Guduchi'' ( | ''Guduchi'' (गुडूची), commonly known as ' Giloy', is the Sanskrit name for the medicinal plant Tinospora cordifolia (Willd.) Hook. f. & Thomson of the family [[Menispermaceae]].<ref name="AYUSHDossier">{{Cite web |url=https://ayush.gov.in/resources/pdf/quality_standards/guduchi_Book-Dossier.pdf |title=Technical Dossier on - Guduchi |format=PDF |publisher=Ministry of AYUSH, Government of India |year=2019 |access-date=2026-04-13}}</ref> It holds a prominent place in [[Ayurveda]] as a [[Rasayana]] (rejuvenative) herb and is widely used for conditions such as fever, jaundice, musculoskeletal disorders, skin diseases, and metabolic ailments.<ref name="AYUSHDossier"/> | ||
| Line 15: | Line 15: | ||
|data4 = Available | |data4 = Available | ||
|label5 = Contributors | |label5 = Contributors | ||
|data5 = | |data5 = Deole Y.S. | ||
|label6 = Year of publication | |label6 = Year of publication | ||
|data6 = 2026 | |data6 = 2026 | ||
| Line 486: | Line 486: | ||
== Current research trends == | == Current research trends == | ||
PubMed‑based trend analyses indicate a substantial increase in publications on Guduchi, rising from several hundred articles in the early 2010s to over 900 indexed studies by 2024, reflecting growing scientific interest. | PubMed‑based trend analyses indicate a substantial increase in publications on Guduchi, rising from several hundred articles in the early 2010s to over 900 indexed studies by 2024, reflecting growing scientific interest.<ref name="AYUSHDossier"/> This growth reflects heightened scientific and public interest but does not, by itself, equate to high‑quality clinical evidence.<ref name="MetabolicReview2025"/> | ||
Most of the current evidence is from preclinical studies, mechanistic investigations, small trials, and narrative reviews; large, well‑designed randomized controlled trials are still limited.<ref name="MetabolicReview2025 | Most of the current evidence is from preclinical studies, mechanistic investigations, small trials, and narrative reviews; large, well‑designed randomized controlled trials are still limited.<ref name="MetabolicReview2025"/> | ||
== Clinical position == | == Clinical position == | ||
From an Ayurvedic perspective, Guduchi is regarded as a classical Rasayana with broad therapeutic indications, supported by long‑standing clinical experience.<ref name="AYUSHDossier"/><ref name="OnePlantManyRoles"/> From a modern evidence‑based medicine standpoint, it is best viewed as a promising but not yet fully established botanical agent for conditions such as metabolic syndrome, certain inflammatory disorders, and liver and immune‑mediated conditions.<ref name="MetabolicReview2025 | From an Ayurvedic perspective, Guduchi is regarded as a classical Rasayana with broad therapeutic indications, supported by long‑standing clinical experience.<ref name="AYUSHDossier"/><ref name="OnePlantManyRoles"/> From a modern evidence‑based medicine standpoint, it is best viewed as a promising but not yet fully established botanical agent for conditions such as metabolic syndrome, certain inflammatory disorders, and liver and immune‑mediated conditions.<ref name="MetabolicReview2025"/> | ||
Use in clinical practice should emphasize:<ref name="LiverTox"/><ref name="AYUSHDossier"/> | Use in clinical practice should emphasize:<ref name="LiverTox"/><ref name="AYUSHDossier"/> | ||